 Jordyn Tyson No 10.86 net shares | 92.0¢ / 100.0¢ | -$9.99 (-100.0%) | $5.43 5.43 shares | Apr 20, 2026 4:13 AM | |
Exact Score: 3-1 No 10.47 net shares | 96.1¢ / 100.0¢ | -$10.1 (-100.1%) | $5.23 5.23 shares | Apr 27, 2026 3:14 AM | |
 ↓ 75,000 No 10.36 net shares | 96.6¢ / 99.9¢ | -$10 (-100.0%) | $5.17 5.18 shares | Apr 27, 2026 10:13 AM | |
Exact Score: 0-2 No 10.31 net shares | 97.1¢ / 100.0¢ | -$10 (-100.1%) | $5.16 5.16 shares | Apr 27, 2026 6:02 PM | |
 ↓ $68 No 10.82 net shares | 92.0¢ / 94.0¢ | -$9.95 (-100.0%) | $5.09 5.41 shares | Apr 27, 2026 12:14 AM | |
82,000 No 10.27 net shares | 96.7¢ / 96.4¢ | -$9.95 (-100.3%) | $4.95 5.14 shares | Apr 27, 2026 3:30 PM | |
 FDA approves Sanofi’s Subcutaneous Sarclisa? Yes 11.12 net shares | 90.0¢ / 1.0¢ | -$10 (-100.0%) | $0.06 5.56 shares | Apr 20, 2026 7:07 AM |
